CM
ABOS icon

Caption Management’s Acumen Pharmaceuticals ABOS Stock Holding History

Caption Management’s Portfolio ABOS Stock Details ABOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-40,000
Closed -$151K – 1130
2023
Q4 		$154K Hold
40,000
– – ﹤0.01% 1146
2023
Q3 		$166K Buy
+40,000
New +$247K ﹤0.01% 1112

Other funds holding ABOS

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KIA
Knollwood Investment Advisory Hunt Valley, Maryland $992M AUM 28.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Caption Management's ABOS Position: Q1 2024 in Review

Caption Management sold out of Acumen Pharmaceuticals (ABOS) in Q1 2024, closing a stake of 40,000 shares — an estimated $151K sold.

Caption Management first reported a position in ABOS in Q3 2023 and held it in 2 quarters. The position peaked at $166K in Q3 2023. 80 funds tracked by Wall St. Rank hold ABOS as of Q1 2024.

  • Caption Management reported no remaining Acumen Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Caption Management sold 40,000 Acumen Pharmaceuticals shares in Q1 2024, an estimated $151K.
  • Caption Management first reported a position in Acumen Pharmaceuticals in Q3 2023 and held it in 2 quarters.
  • Caption Management's Acumen Pharmaceuticals position peaked at $166K in Q3 2023.
  • 80 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q1 2024.

Based on Caption Management's 13F filing for Q1 2024, filed 15 May 2024.